EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY-NC-SA 4.0

Hep-2000 indirect immunofluorescence assay – An emerging screening tool for detection of antinuclear autoantibodies in various connective tissue disorders

Arpita Singh, Shilpi Sahu, Neha R Jadhav, Navdeep Kaur

Indian Journal of Pathology and Microbiology · 2024

DOI: 10.4103/ijpm.ijpm_827_23 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Indian Journal of Pathology and Microbiology, 2024. Verfasst von Arpita Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, MGM Medical College, Kamothe, Navi Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Connective Tissue Diseases, Antibodies, Antinuclear, Sensitivity and Specificity. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Connective tissue disorders (CTD’s) are a group of autoimmune disorders having multifactorial etiology, multisystem involvement and overlapping clinical features. Their prevalence has been increasing in India, with Systemic lupus erythematosus (SLE) being the most common CTD, affecting mostly females. Antinuclear Antibodies (ANA) directed against a variety of nuclear antigens detectable in the serum are used for screening, diagnoses, and monitoring of autoimmune diseases, with immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) being the most widely used methods.

Aims

1.To evaluate the diagnostic significance of IFA in screening of Autoimmune CTDs. 2.To study different titres and patterns shown by ANA positive samples. Materials and Methods: For IFA, patient’s sera is incubated with substrate cells, and bound antibodies are detected by incubation with a dye-conjugated anti-human immunoglobulin which are visualized by fluorescent microscopy and different ANA titres and patterns were analysed.

Results

57 samples were examined for ANA by Indirect IFA, of which 21 (36.8%) were ANA positive with a female preponderance (71.9%) in the peri-menopausal age group. Most common pattern reported was Speckled followed by Homogenous. The sensitivity & specificity of IIFA was found to be comparable with ELISA.

Conclusion

CTD’s are a group of autoimmune disorders with a plethora of clinical presentations, necessitating the need of a more specific and accurate screening test. ANA by IIFA gives patterns, which are associated with specific antibodies that help in reaching a diagnosis. ANA testing is a cost effective and non-invasive technique that can be used as a reliable screening test for Autoimmune disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Connective Tissue DiseasesAntibodies, AntinuclearSensitivity and SpecificityHumansFluorescent Antibody Technique, IndirectFemaleMaleAdultMiddle AgedIndiaYoung AdultAgedAdolescentMass ScreeningEnzyme-Linked Immunosorbent AssayAutoimmune Diseases

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Department of Pathology, MGM Medical College, Kamothe, Navi Mumbai, Maharashtra, India.

Zitieren

APA

Singh, A., Sahu, S., Jadhav, N. R., & Kaur, N. (2024). Hep-2000 indirect immunofluorescence assay – An emerging screening tool for detection of antinuclear autoantibodies in various connective tissue disorders. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_827_23

Vancouver

Singh A, Sahu S, Jadhav NR, Kaur N. Hep-2000 indirect immunofluorescence assay – An emerging screening tool for detection of antinuclear autoantibodies in various connective tissue disorders. Indian Journal of Pathology and Microbiology. 2024. doi:10.4103/ijpm.ijpm_827_23

BibTeX
@article{Singh2024,
  author = {Singh, Arpita and Sahu, Shilpi and Jadhav, Neha R and Kaur, Navdeep},
  title = {Hep-2000 indirect immunofluorescence assay – An emerging screening tool for detection of antinuclear autoantibodies in various connective tissue disorders},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2024},
  doi = {10.4103/ijpm.ijpm_827_23}
}
Kostenlos starten →